Meeder Asset Management’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-116
Closed -$10.1K 914
2024
Q2
$10.1K Buy
+116
New +$12.1K ﹤0.01% 651
2022
Q2
Sell
-174
Closed -$44K 2333
2022
Q1
$44K Buy
+174
New +$47.3K ﹤0.01% 1004
2021
Q4
Sell
-174
Closed -$53K 1866
2021
Q3
$53K Hold
174
﹤0.01% 1071
2021
Q2
$47K Hold
174
﹤0.01% 1150
2021
Q1
$42K Buy
+174
New +$47.9K ﹤0.01% 1165

Other funds holding MLAB

Meeder Asset Management's MLAB Position: Q3 2024 in Review

Meeder Asset Management sold out of Mesa Laboratories (MLAB) in Q3 2024, closing a stake of 116 shares — an estimated $10.1K sold.

Meeder Asset Management first reported a position in MLAB in Q1 2021 and held it in 5 quarters. The position peaked at $53K in Q3 2021. 166 funds tracked by Wall St. Rank hold MLAB as of Q3 2024.

  • Meeder Asset Management reported no remaining Mesa Laboratories position as of Q3 2024 after selling out during the quarter.
  • Meeder Asset Management sold 116 Mesa Laboratories shares in Q3 2024, an estimated $10.1K.
  • Meeder Asset Management first reported a position in Mesa Laboratories in Q1 2021 and held it in 5 quarters.
  • Meeder Asset Management's Mesa Laboratories position peaked at $53K in Q3 2021.
  • 166 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2024.

Based on Meeder Asset Management's 13F filing for Q3 2024, filed 7 Nov 2024.